It has been nearly two years since the pandemic caused by the novel coronavirus disease
(COVID-19) has affected the world. Several innovations and discoveries related to COVID …

Many people infected with the SARS-CoV-2 suffer long-term symptoms, such as “brain fog”,
fatigue and clotting problems. Explanations for “long COVID” include immune imbalance …

Mucormycosis is a potentially lethal, angioinvasive fungal infection predisposed by diabetes
mellitus, corticosteroids and immunosuppressive drugs, primary or secondary …

Coronavirus disease 2019 (COVID-19) vaccines can cause transient local and systemic post-
vaccination reactions. The aim of this study was to report uveitis and other ocular …

Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …

Objectives: Summarize the epidemiology of ocular manifestations of COVID-19. Describe
the typical presentation of a patient with ocular manifestations of COVID-19. Outline …

Several COVID-19 vaccines have been developed and approved for use around the world
from December 2020, to combat the pandemic caused by the novel SARS-CoV-2 virus …

The SARS-CoV-2 genome has undergone several mutations since the beginning of the
pandemic in December 2019. A number of these mutants were associated with higher …

Neuroophthalmic manifestations are very rare in corona virus disease-19 (COVID-19)
infection. Only few reports have been published till date describing COVID-19-associated …

Central retinal vein occlusion (CRVO) and other thromboembolic events have been
extensively documented after infections with SARS-Cov2 [1, 2]. We observed a 50-year-old …